Quetmolimab: A Deep Dive into KANAb 001 and E-6011 Quetmo compound, quetmolimab, shows a novel approach aimed at the PD-1 receptor. First medical results from these programs, KANAb 001 and E-6011, reveal positive https://www.targetmol.com/compound/quetmolimab